Core Points - The CSI Tencent Ji'an Value 100 A-Share Index has shown significant growth, with a 6.92% increase over the past month, 13.78% over the past three months, and 14.10% year-to-date [1] - The index is composed of 100 listed companies selected based on their investment value assessments by Tencent and Ji'an Jinxin's evaluation committee [1] - The index's top ten holdings include Huaguang Huaneng (1.94%), Chenxin Pharmaceutical (1.92%), and Taotao Automotive (1.8%) among others [1] Market Composition - The CSI Tencent Ji'an Value 100 A-Share Index is primarily composed of stocks from the Shanghai Stock Exchange (64.71%) and Shenzhen Stock Exchange (35.29%) [1] - The industry distribution of the index shows that Industrial sector holds 27.80%, Consumer Discretionary 17.84%, and Materials 12.44% among others [2] Index Management - The index samples are adjusted biannually, with changes implemented on the next trading day after the second Friday of June and December [2] - In special circumstances, the index may undergo temporary adjustments, such as when a sample company is delisted or undergoes significant corporate changes [2] Fund Tracking - Public funds tracking the CSI Tencent Ji'an include the Galaxy Regular Investment Fund [3]

Core Viewpoint - The A-share market for baby and child-related stocks experienced a significant increase, driven by recent government policies aimed at promoting early childhood education and providing financial support for families with young children [1][2]. Group 1: Stock Performance - Qide New Materials (300995) saw an increase of 8.47%, with a total market value of 3.956 billion and a year-to-date increase of 198.59% [2]. - Chenxin Pharmaceutical (603367) rose by 7.29%, with a market capitalization of 14.6 billion and a year-to-date increase of 138.23% [2]. - Helen Piano (300329) increased by 5.64%, with a market value of 3.219 billion and a year-to-date increase of 149.00% [2]. - Hejing Technology (300279) grew by 4.95%, with a market capitalization of 3.942 billion and a year-to-date increase of 33.00% [2]. - Chuangyuan Co. (300703) rose by 4.36%, with a market value of 4.365 billion and a year-to-date increase of 71.09% [2]. - Beingmate (002570) increased by 4.24%, with a market capitalization of 7.971 billion and a year-to-date increase of 75.30% [2]. - Angli Education (600661) saw a rise of 3.95%, with a market value of 3.393 billion and a year-to-date increase of 1.02% [2]. Group 2: Government Policies - The State Council issued an opinion on August 5 to gradually implement free preschool education, starting from the fall semester of 2025, which will waive the care and education fees for children in public kindergartens [2]. - A new implementation plan for a childcare subsidy system was released on July 28, which will provide cash subsidies to families with children under three years old, starting from January 1, 2025. The current basic standard for the subsidy is 3,600 yuan per child per year [2].

● 持股5%以上大股东持股的基本情况 本次减持计划实施前，辰欣药业股份有限公司（以下简称"公司"或"辰欣药业"）持股5%以上股东韩延 振持有辰欣药业无限售流通股份31,977,829 股，占辰欣药业总股本的 7.06%。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 减持计划的主要内容 自本公告披露之日起满15个交易日后的3个月内，根据市场情况，做出适当减持安排。韩延振拟通过集 中竞价交易方式减持数量不超过4,527,541股，不超过公司总股本的1%；拟通过大宗交易方式减持数量 不超过9,055,082股，不超过公司总股本的2%，合计减持数量不超过13,582,623股，不超过公司总股本的 3%。在任意连续90日内，集中竞价减持股份的总数不超过公司股份总数的1%，大宗交易减持股份的总 数不超过公司股份总数2%。在上述减持计划实施期间，公司发生派发红利、送红股、转增股本、增发 新股或配股等股本变动股本除权、除息事项的，韩延振可以对减持计划进行相应调 ...

Macro News - The State Council issued opinions on gradually promoting free preschool education, stating that from the fall semester of 2025, public kindergarten tuition fees for the last year will be waived [1] - Seven departments, including the central bank, jointly issued guidelines to support new industrialization, aiming for a mature financial system for high-end, intelligent, and green manufacturing by 2027 [1] - The National Health Commission and 16 departments released an implementation plan for the "Healthy China Action - Healthy Environment Promotion Action (2025-2030)", with goals to improve drinking water quality and health literacy by 2030 [1] - Regulatory authorities are intensifying efforts to combat market fraud by punishing third-party companies that assist in fraudulent activities for listed companies [1] Industry News - The China Electromechanical Products Import and Export Chamber urged photovoltaic companies to adhere to fair competition principles and control capacity expansion according to global market demand [2] - Trump announced plans to impose drug tariffs, starting small but potentially reaching 250% [2] - The Guizhou Provincial Market Supervision Administration held discussions with travel platform companies to enforce compliance with laws and maintain a fair market environment [2] Company News - Upstream New Materials announced that it may apply for a continuous suspension of trading if its stock price continues to rise [6] - The Shanghai Stock Exchange reported abnormal trading behaviors affecting market order related to Upstream New Materials, leading to account trading suspensions for certain investors [6] Global Market - Major US stock indices closed lower, with the Dow down 0.14%, Nasdaq down 0.65%, and S&P 500 down 0.49% [7] - WTI crude oil futures fell by 1.7% to $65.16 per barrel, while Brent crude oil futures dropped by 1.63% to $67.64 per barrel [8] - COMEX gold futures rose by 0.25% to $3435 per ounce, and silver futures increased by 1.36% to $37.835 per ounce [9] New Stock Information - New stock HanSang Technology (301491) has an issue price of 28.91 with a PE ratio of 14.90, focusing on high-end audio products and solutions [10]

盘后数据显示，8月5日龙虎榜中，共34只个股出现了机构的身影，18只股票呈现机构净买入，16只股票 呈现机构净卖出。当天机构净买入前三的股票分别是东杰智能、新瀚新材、共创草坪，净买入金额分别 是2.09亿元、8480万元、6312万元。当天机构净卖出前三的股票分别是昂利康、辰欣药业、山河智能， 净流出金额分别是1.16亿元、7422万元、5128万元。（第一财经） ...

Core Viewpoint - Chenxin Pharmaceutical (603367.SH) announced a plan for share reduction by its shareholder Han Yanzhen, which will take place within three months after a 15 trading day period following the announcement [1] Summary by Category Share Reduction Plan - Han Yanzhen intends to reduce holdings through centralized bidding, with a maximum of 4.5275 million shares, accounting for no more than 1% of the company's total share capital [1] - Additionally, Han Yanzhen plans to reduce holdings via block trading, with a maximum of 9.0551 million shares, representing no more than 2% of the company's total share capital [1] - The total reduction will not exceed 13.5826 million shares, which is up to 3% of the company's total share capital [1]

证券代码：603367 证券简称：辰欣药业 公告编号：2025-037 辰欣药业股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 持股 5%以上大股东持股的基本情况 本次减持计划实施前，辰欣药业股份有限公司（以下简称"公司"或"辰欣 药业"）持股 5%以上股东韩延振持有辰欣药业无限售流通股份 31,977,829 股， 占辰欣药业总股本的 7.06%。 减持计划的主要内容 自本公告披露之日起满 15 个交易日后的 3 个月内，根据市场情况，做出适 当减持安排。韩延振拟通过集中竞价交易方式减持数量不超过 4,527,541 股，不 超过公司总股本的 1%；拟通过大宗交易方式减持数量不超过 9,055,082 股，不 超过公司总股本的 2%，合计减持数量不超过 13,582,623 股，不超过公司总股本 的 3%。在任意连续 90 日内，集中竞价减持股份的总数不超过公司股份总数的 1%， 大宗交易减持股份的总数不超过公司股份总数 2%。在上述减持计划实施 ...

辰欣药业（SH 603367，收盘价：30.04元）8月5日晚间发布公告称，本次减持计划实施前，辰欣药业股 份有限公司持股5%以上股东韩延振持有辰欣药业无限售流通股份约3198万股，占辰欣药业总股本的 7.06%。自本公告披露之日起满15个交易日后的3个月内，根据市场情况，做出适当减持安排。韩延振 拟通过集中竞价交易方式减持数量不超过约453万股，不超过公司总股本的1%；拟通过大宗交易方式减 持数量不超过约906万股，不超过公司总股本的2%，合计减持数量不超过约1358万股，不超过公司总股 本的3%。在任意连续90日内，集中竞价减持股份的总数不超过公司股份总数的1%，大宗交易减持股份 的总数不超过公司股份总数2%。在相关减持计划实施期间，公司发生派发红利、送红股、转增股本、 增发新股或配股等股本变动股本除权、除息事项的，韩延振可以对减持计划进行相应调整。 （文章来源：每日经济新闻） 2024年1至12月份，辰欣药业的营业收入构成为：医药制造业占比99.75%，其他业务占比0.25%。 ...

Group 1 - The stock of Aonlikang is approaching a limit down, indicating significant selling pressure [1] - Several pharmaceutical companies, including Nanjing New Pharmaceutical, Huason Pharmaceutical, Yuekang Pharmaceutical, Chenxin Pharmaceutical, Guizhou Bailing, and Shutaishen, have all experienced declines exceeding 6% [1]

金融界消息 截至2025年8月4日收盘，辰欣药业（603367）报收于32.18元，上涨6.59%，换手率 10.84%，成交量49.07万手，成交金额15.11亿元。 天眼查商业履历信息显示，辰欣药业股份有限公司，成立于1998年，位于济宁市，是一家以从事医药制 造业为主的企业。企业注册资本45275.4129万人民币，实缴资本35335.3万人民币。公司法定代表人为杜 振新。 通过天眼查大数据分析，辰欣药业股份有限公司共对外投资了18家企业，参与招投标项目5000次，知识 产权方面有商标信息230条，专利信息290条，此外企业还拥有行政许可610个。 来源：金融界 资金流向方面，今日主力资金净流入7313.84万元，占比成交额4.84%。其中，超大单净流出566.83万 元、占成交额0.38%，大单净流入7880.67万元、占成交额5.21%，中单净流出流入1374.58万元、占成交 额0.91%，小单净流出8688.42万元、占成交额5.75%。 辰欣药业最新一期业绩显示，截至2025一季报，公司营业总收入9.20亿元、同比减少19.91%，归属净利 润1.44亿元，同比减少11.86%，扣非净利润1. ...